GSK172981 is a potent and selective non-peptide antagonist of the tachykinin NK3 receptor, with high affinity for both human and guinea pig receptors. It has demonstrated competitive antagonism in vitro and is a research tool for studying schizophrenia and related central nervous system disorders.